Industry News
Genomic Alterations Tied To Kidney Tumor Aggressiveness Identified
Jun 26, 2013
Investigators in The Cancer Genome Atlas (TCGA) Research Network have uncovered a connection between how tumor cells use energy from metabolic processes and the aggressiveness of the most common form of kidney cancer, clear cell renal cell carcinoma (ccRCC)... Read More
Hunger For Amino Acids Makes Brain Cancer More Aggressive
Jun 26, 2013
To fuel phases of fast and aggressive growth, tumors need higher-than-normal amounts of energy and the molecular building blocks needed to build new cellular components. Cancer cells therefore consume a lot of sugar (glucose A number of tumors are also able to catabolize the amino acid glutamine, an important building block of proteins... Read More
Breast Cancer Stem Cells Destroyed By Targeted Viral Therapy In Preclinical Experiments
Jun 26, 2013
A promising new treatment for breast cancer being developed at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) has been shown in cell culture and in animal models to selectively kill cancer stem cells at the original tumor site and in distant metastases with no toxic effects on healthy cells, including normal stem cells... Read More
Advanced Prostate Cancer Treatment Usage Rising Fast In Low Risk Patients
Jun 26, 2013
More men with low-risk prostate are undergoing advanced treatment, including robotic prostatectomies and intensity-modulated radiotherapy, even though their risk of non-cancer mortality is much higher, researchers from University of Michigan, Ann Arbor, reported in JAMA (June 26th 2013 issue)... Read More
High-End Treatment For Low Risk Prostate Cancer Rising
Jun 26, 2013
More men with low-risk prostate are undergoing robotic prostatectomies and intensity-modulated radiotherapy, even though their risk of non-cancer mortality is much higher, researchers from University of Michigan, Ann Arbor, reported in JAMA (June 26th 2013 issue). The authors added that these low-risk prostate cancer patients will likely not benefit from advanced treatment technologies... Read More
First Stage Study Finds Potential New Drugs For Neuroblastoma
Jun 26, 2013
Scientists at The Institute of Cancer Research, London have made a step towards new, targeted drugs for children with the highestrisk form of a childhood cancer called neuroblastoma. In a preclinical study, published in journal Cancer Cell , researchers successfully used two potential drugs to target cancerous neuroblastoma cells with an overactive gene called MYCN... Read More
News From The Journal Of Clinical Investigation: June 24, 2013
Jun 26, 2013
Gene dysregulation underlies preeclampsia Preeclampsia is a medical condition affecting 4-8% of pregnancies that is characterized by high maternal blood pressure, excess protein in maternal urine, and reduced fetal growth. If left untreated, it can develop into eclampsia, which causes life threatening seizures. Apart from delivery, there is no known cure... Read More
Increase Seen In Use Of Advanced Treatment Technologies For Prostate Cancer Among Men With Low Risk Disease
Jun 25, 2013
Use of advanced treatment technologies for prostate cancer, such as intensitymodulated radiotherapy and robotic prostatectomy, has increased among men with lowrisk disease, high risk of noncancer mortality, or both, a population of patients who are unlikely to benefit from these treatments, according to a study in the June 26 issue of JAMA... Read More
Gene Mutation May Have Effect On Benefit Of Aspirin Use For Colorectal Cancer
Jun 25, 2013
In 2 large studies, the association between aspirin use and risk of colorectal cancer was affected by mutation of the gene BRAF, with regular aspirin use associated with a lower risk of BRAFwildtype colorectal cancer but not with risk of BRAFmutated cancer, findings that suggest that BRAFmutant colon tumor cells may be less sensitive to the effect of aspirin, according to a stu... Read More
How Safe Is Splenda (Sucralose)?
Jun 25, 2013
Splenda (sucralose) is being downgraded from "safe" to "caution" after an Italian animal study linked sucralose to a higher risk of developing leukemia. The Center for Science in the Public Interest (CSPI) says it awaits the Italian study's review before deciding what long-term safety grade to assign to Splenda in its Chemical Cuisine guide to food additives... Read More
Previous Page Next Page